Solesis

Solesis develops and manufactures biomaterials solutions and critical components for the medical device and biopharmaceutical industries. Working across materials science, medical textiles, polymers, bioresorbables and hybrid materials, the company supplies healthcare innovators with customisable biomaterial offerings used in medical devices and delivery systems. Its work also extends to custom excipients for controlled-release medical devices and to polymer-based single-use solutions for biological fluid handling and cell growth in advanced therapies.

The group operates through a family of companies: Secant Group, Polyzen, Charter Medical and SanaVita Medical. Together they employ more than 500 people across seven sites, with more than 80 years of materials expertise behind them and over 50 vascular device integrations to date. The company's technical domains span bioresorbables, controlled-release excipients, single-use polymer solutions and support for advanced therapy manufacturing.

Solesis is headquartered in Telford, Pennsylvania, and maintains a presence in the United States and Costa Rica. It works in partnership with MedTech and pharmaceutical innovators, with a stated focus on materials science and turning ideas into medical breakthroughs.